Part ofhealth →

SRES184FEDERALin_committee

Senate Resolution Supporting Parkinson's Awareness Month

Original title: A resolution expressing support for the designation of April 2023 as "Parkinson's Awareness Month".

April 29, 2025

health Parkinson's disease medical research awareness

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1424)Apr 27, 2023

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This serves as a formal statement of congressional intent to prioritize Parkinson's disease research and awareness, though it does not mandate specific funding or new legal requirements.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Individuals with Parkinson's disease

The resolution acknowledges their health challenges and the importance of clinical trials they participate in.

Family caregivers

The resolution recognizes the impact of the disease on the lives of caregivers and loved ones.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This formally expresses the U.S. Senate's support for designating April 2023 as Parkinson's Awareness Month. It highlights the prevalence of the disease and the need for continued research and support services.

Key Facts

The Senate designates April 2023 as Parkinson's Awareness Month.
Parkinson's disease affects over 1,000,000 individuals in the United States.
Parkinson's is the 14th leading cause of death in the United States.
The number of individuals with Parkinson's in the U.S. is projected to nearly double by 2037.
The annual cost of Parkinson's disease in the U.S. is estimated to be at least $80,000,000,000.
The Senate commits to continuing support for research into treatments and a cure.
The resolution recognizes participants in clinical trials and the work of caregivers and researchers.

Frequently Asked Questions

Does this resolution provide funding for Parkinson's research?

No, this is a non-binding expressing support for awareness and research goals; it does not allocate specific federal funds.

What is the purpose of this document?

The purpose is to formally recognize April 2023 as Parkinson's Awareness Month and acknowledge the impact of the disease on patients and their families.

Why It Matters

This serves as a formal statement of congressional intent to prioritize Parkinson's disease research and awareness, though it does not mandate specific funding or new legal requirements.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Projected Economic Impact

The document cites a specific projection that the annual cost of Parkinson's disease will reach $80 billion by 2037.

United States

Connected Entities

personDebbie Stabenow“U.S. Senator who introduced the resolution.”Map →

organizationCenters for Disease Control and Prevention“Cited as the source for mortality data regarding Parkinson's disease.”Map →

organizationCommittee on Health, Education, Labor, and Pensions“The Senate committee to which the resolution was referred.”Map →

personRick Scott“U.S. Senator who co-sponsored the resolution.”Map →

Analysis Score

0–100

Significance20
How much this matters to a regular citizen
Controversy0
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools